Beta-2-Crosslaps CTx-1 Plasma

Description

The Beta-2-Crosslaps CTx-1 Plasma test measures the level of C-terminal telopeptide (CTx-1), a specific marker of bone resorption, in the blood. This test is crucial in assessing the rate of bone turnover, which is particularly important in diagnosing and monitoring osteoporosis and other metabolic bone diseases. Elevated levels of CTx-1 indicate increased bone breakdown, which can suggest an increased risk of osteoporosis or ongoing bone loss. This test is valuable for evaluating the effectiveness of osteoporosis treatments, as decreasing CTx-1 levels often indicate a positive response to therapy. It’s also used in research to study new bone-active drugs and to assess fracture risk in certain populations. Regular monitoring with this test can help guide treatment decisions and assess the progression of bone-related conditions.